Correlation Between PetroChina Company and Diamyd Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PetroChina Company and Diamyd Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PetroChina Company and Diamyd Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PetroChina Company Limited and Diamyd Medical AB, you can compare the effects of market volatilities on PetroChina Company and Diamyd Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PetroChina Company with a short position of Diamyd Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of PetroChina Company and Diamyd Medical.

Diversification Opportunities for PetroChina Company and Diamyd Medical

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between PetroChina and Diamyd is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding PetroChina Company Limited and Diamyd Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diamyd Medical AB and PetroChina Company is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PetroChina Company Limited are associated (or correlated) with Diamyd Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diamyd Medical AB has no effect on the direction of PetroChina Company i.e., PetroChina Company and Diamyd Medical go up and down completely randomly.

Pair Corralation between PetroChina Company and Diamyd Medical

Assuming the 90 days horizon PetroChina Company Limited is expected to under-perform the Diamyd Medical. But the stock apears to be less risky and, when comparing its historical volatility, PetroChina Company Limited is 2.86 times less risky than Diamyd Medical. The stock trades about -0.08 of its potential returns per unit of risk. The Diamyd Medical AB is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  109.00  in Diamyd Medical AB on September 2, 2024 and sell it today you would earn a total of  3.00  from holding Diamyd Medical AB or generate 2.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

PetroChina Company Limited  vs.  Diamyd Medical AB

 Performance 
       Timeline  
PetroChina Limited 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in PetroChina Company Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, PetroChina Company reported solid returns over the last few months and may actually be approaching a breakup point.
Diamyd Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diamyd Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

PetroChina Company and Diamyd Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PetroChina Company and Diamyd Medical

The main advantage of trading using opposite PetroChina Company and Diamyd Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PetroChina Company position performs unexpectedly, Diamyd Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diamyd Medical will offset losses from the drop in Diamyd Medical's long position.
The idea behind PetroChina Company Limited and Diamyd Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm